Emera Incorporated EMA
51.61 USD +0.07 (+0.14%)
Regular-session close
51.61 0.00 0.00%
After hours · Nov 18, 4:00 PM ET
51.27 Day range 51.81
45.27 52-week range 55.49
- YTD
- +4.81%
- 1 year
- +5.43%
News
defenseworld.net eMagin (NYSE:EMA) Stock Breaks Above 200 Day Moving Average – Time to Sell? eMagin Corporation (NYSE: EMA - Get Free Report) crossed above its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $51.21 and traded as high…benzinga.com Emera Sees 2026 Adjusted EPS Growth Above 5%-7% Target Range; Maintains 5%-7% Annual Adjusted EPS Growth Target Through 2030 Emera (TSX:EMA) expect to deliver 2026 adjusted EPS growth above its annual target range of 5%-7%, while maintaining its target of 5%-7% annual adjusted EPS growth through 2030.
benzinga.com Emera Q3 Adj. EPS C$0.85 Misses C$0.93 Estimate, Sales C$1.984B Miss C$2.000B Estimate Emera (TSX:EMA) reported quarterly earnings of C$0.85 per share which missed the analyst consensus estimate of C$0.93 by 8.6 percent. This is a 3.41 percent decrease over earnings of C$0.88 per share…
benzinga.com Emera Q3 Adj. EPS C$0.85 Misses C$0.93 Estimate Emera (TSX:EMA) reported quarterly earnings of $0.85 per share which missed the analyst consensus estimate of $0.93 by 8.6 percent. This is a 3.41 percent decrease over earnings of $0.88 per share…
benzinga.com Enbridge, Moderna On Deck Friday As Demand, Vaccine Pipeline Face Test Enbridge headlines Friday’s reports, with investors weighing whether resilient pipeline utilization can offset a softer revenue comparison. Moderna, Brookfield Asset Management, Humana, Vistra, PPL,…benzinga.com Barclays Maintains Equal-Weight on Emera, Lowers Price Target to $50 Barclays analyst Nicholas Campanella maintains Emera (NYSE:EMA) with a Equal-Weight and lowers the price target from $53 to $50.
